Patent · US Active

Antisense compositions and methods of making and using same

US9499819B2 · kind B2 · utility

14Cited by

14References

28Claims

0Family size

Assignee

Nogra Pharma Limited · IE

Inventors

Sergio Baroni · Rossera, IT
Salvatore Bellinvia · Balerna, CH
Francesca Viti · Salorino, CH

Key dates

Filing date	Dec 15, 2014
Grant date	Nov 22, 2016
Priority date	—
Expiry date	Dec 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations can be used to treat Crohn's disease, ulcerative colitis and chronic inflammatory bowel disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.